BIA
ABMD

Bell Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Bell Investment Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18
Closed -$4K – 2061
2022
Q3 		$4K Hold
18
– – ﹤0.01% 858
2022
Q2 		$4K Buy
+18
New +$4.86K ﹤0.01% 879
2021
Q4 		$3K Buy
9
+2
+29% +$676 ﹤0.01% 1067
2021
Q3 		$2K Buy
+7
New +$2.37K ﹤0.01% 1213

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bell Investment Advisors's ABMD Position: Q4 2022 in Review

Bell Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 18 shares — an estimated $4K sold.

Bell Investment Advisors first reported a position in ABMD in Q3 2021 and held it in 4 quarters. The position peaked at $4K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bell Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bell Investment Advisors sold 18 Abiomed Inc shares in Q4 2022, an estimated $4K.
  • Bell Investment Advisors first reported a position in Abiomed Inc in Q3 2021 and held it in 4 quarters.
  • Bell Investment Advisors's Abiomed Inc position peaked at $4K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bell Investment Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.